Sarah Spinler is professor and chair of the Department of Pharmacy Practice at the Binghamton University School of Pharmacy and Pharmaceutical Sciences. She is also professor emeritus of the Philadelphia College of Pharmacy at the University of the Sciences (USciences) in Philadelphia, and adjunct professor in the Cardiovascular Division of the Department of Medicine at the University of Pennsylvania. Spinler received her bachelor of science and Doctor of Pharmacy degrees from the University of Minnesota in Minneapolis. She completed a pharmacy residency and research fellowship in cardiovascular critical care pharmacy at the University of Illinois at Chicago. She is board certified in Pharmacotherapy with added qualifications in Cardiology (BSPS AQ-Cardiology).
Spinler has served as a fellow, PGY-1 and PGY2 Cardiology residency program director for 15 trainees and oversaw the pharmaceutical industry fellowship program at USciences for eight years. She received the Award for Sustained Contributions to the Literature of Pharmacy Practice from the American Society of Health-System Pharmacists (ASHP) and served as regent of the American College of Clinical Pharmacy (ACCP). In 2019 she received the American College of Clinical Pharmacy (ACCP) Cardiology Practice and Research Network’s Lifetime Achievement Award.
She has authored more than 300 research articles, reviews and book chapters and has given more than 400 continuing education programs in the areas of acute coronary syndrome, venous thromboembolism antiplatelets and anticoagulants.
Spinler was a member of the Steering Committee for the acute coronary syndrome CRUSADE Registry, a member of the Steering Committee and Research Committee of the American College of Cardiology (ACC) National Cardiovascular Data Registry (NCDR®) Practice Innovation and Clinical Excellence (PINNACLE RegistryTM) and currently serves on the editorial boards of several biomedical journals including Annals of Pharmacotherapy, Pharmacotherapy, American Journal of Managed Care and Drugs. She also serves on the ACC’s CathPCI Bleeding Campaign Steering Committee, the Writing Committee for the Clinical Decision Pathway on Using Dual Antiplatelet Therapy with Oral Anticoagulants, and on the Cardiology Council of the Board of Pharmaceutical Specialties for the new certification as Cardiology Board Certified Pharmacist (BCCP).
- Cheng JWM, Colucci V, Kalus JS, Spinler SA. Focused updates: SGLT2 inhibitors in patients with heart failure and/or chronic kidney disease. Ann Pharmacother. 2021; eb;55(2):252-260.
- Ali MAM and Spinler SA. COVID-19 and thrombosis: from bench to bedside. Trends Cardiovasc Med. 2021; Apr;31(3):143-160.
- Kumbhani DJ, Cannon CP, Bhatt DL, Cuker A. Gluckman TJ, Marine JE, Messe SR, Patel N, Rosenfield K, Spinler SA, Thourani VH. ACC Expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention or with atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2021 Feb 9;77(5):629-658.
- PharmD, University of Minnesota
- BS Pharmacy, University of Minnesota
- Quality of care and performance measures of cardiovascular medication use
- Anticoagulant use in patients with chronic kidney disease
- Anticoagulation reversal
- American Society of Health-System Pharmacists Award for Sustained Contributions to the Literature of Pharmacy Practice
- Fellow: American College of Clinical Pharmacy
- Fellow: American Heart Association: cardiovascular Clinical Council
- Fellow: American Heart Association: Quality of Care and Outcomes Research Section
- Fellow: Philadelphia College of Physicians
- Fellow: American Society of Health-System Pharmacists
- Associate of the American College of Cardiology
- Philadelphia College of Pharmacy Excellence in Research and Scholarship Award
- Inducted into the Phi Lambda Sigma Pharmacy Leadership Society: Gamma Eta Chapter
- American College of Clinical Pharmacy Cardiology Practice Research Network Lifetime Achievement Award